✦ LIBER ✦

A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy

✍ Scribed by J. Randolph Hecht; Madhavan Pillai; Russell Gollard; William Heim; Forrest Swan; Ravi Patel; Lyndah Dreiling; May Mo; Imtiaz Malik

Book ID: 119935232
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 561 KB
Volume: 9
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2010.n.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase 2b, Double-Blind, Randomized Stu

A Phase 2b, Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared With Placebo (PBO) When Administered in Combination With Chemotherapy (Modified FOLFOX6) for First-line Treatment (tx) of Patients (Pts) With Metastatic Colorectal Cancer (mCRC). The RESPECT Trial

✍ J. Tabernero; R. Garcia-Carbonero; C.H. Könne; P.J. O'Dwyer; A. Sobrero; E. Van 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

✍ Albany, C.; Brames, M. J.; Fausel, C.; Johnson, C. S.; Picus, J.; Einhorn, L. H. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB